Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000568697

Apexbio Technology LLC NAFTOPIDIL-DIHCL-10G
SDP

Catalog No. 5000568697
Encompass_Preferred

Naftopidil DiHCl (CAS No 57149-08-3) is a pharmacological compound primarily used in biomedical research focused on urological and cardiovascular disorders Originating as an alpha-1 adrenergic receptor antagonist it targets specific pathways to reduce smooth muscle contraction particularly in the prostate and bladder aiding in conditions like benign prostatic hyperplasia Its mechanism also involves modulation of blood pressure by affecting vascular resistance In vitro studies often show activity in the nanomolar to low micromolar range Typical applications include experiments using cell models such as prostate or bladder smooth muscle cells as well as animal studies for assessing efficacy and safety in drug screening scenarios Experimental concentrations typically depend on the specific research design allowing for flexibility in studying its pharmacokinetics and therapeutic potential

Catalog No. 50-005-68697 Supplier Apexbio Technology LLC Supplier No. B136610000
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Naftopidil DiHCl (CAS No 57149-08-3) is a pharmacological compound primarily used in biomedical research focused on urological and cardiovascular disorders Originating as an alpha-1 adrenergic receptor antagonist it targets specific pathways to reduce smooth muscle contraction particularly in the prostate and bladder aiding in conditions like benign prostatic hyperplasia Its mechanism also involves modulation of blood pressure by affecting vascular resistance In vitro studies often show activity in the nanomolar to low micromolar range Typical applications include experiments using cell models such as prostate or bladder smooth muscle cells as well as animal studies for assessing efficacy and safety in drug screening scenarios Experimental concentrations typically depend on the specific research design allowing for flexibility in studying its pharmacokinetics and therapeutic potential

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.